当前位置: X-MOL 学术Am. J. Hematol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Early hydroxyurea use is neuroprotective in children with sickle cell anemia
American Journal of Hematology ( IF 10.1 ) Pub Date : 2022-07-14 , DOI: 10.1002/ajh.26664
Kristine Karkoska 1 , Amanda Pfeiffer 2 , Dean W Beebe 3, 4 , Charles T Quinn 2, 4 , Omar Niss 2, 4 , Patrick T McGann 5, 6
Affiliation  

Children with sickle cell disease (SCD) who began hydroyxurea before age five years scored no differently on a measure of cognitive funciton than age, sex, and race-matched unaffected peers.

中文翻译:

早期使用羟基脲对镰状细胞性贫血儿童具有神经保护作用

在五岁之前开始使用羟基脲的镰状细胞病 (SCD) 儿童在认知功能测量上的得分与年龄、性别和种族匹配的未受影响的同龄人没有区别。
更新日期:2022-07-14
down
wechat
bug